ALTS Fundamental Analysis - ALT5 SIGMA CORP

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to ALTS. ALTS was compared to 235 industry peers in the Capital Markets industry. ALTS has a bad profitability rating. Also its financial health evaluation is rather negative. ALTS is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALTS had negative earnings in the past year.

In the past year ALTS has reported a negative cash flow from operations.

In the past 5 years ALTS reported 4 times negative net income.

The reported operating cash flow has been mixed in the past 5 years: ALTS reported negative operating cash flow in multiple years.

1.2 Ratios

ALTS's Return On Assets of -17.60% is on the low side compared to the rest of the industry. ALTS is outperformed by 86.38% of its industry peers.

ALTS's Return On Equity of -55.73% is on the low side compared to the rest of the industry. ALTS is outperformed by 84.26% of its industry peers.

		Industry Rank	Sector Rank
ROA	-17.6%
ROE	-55.73%
ROIC	N/A

ROA(3y)-8.77%

ROA(5y)-34.52%

ROE(3y)-9.86%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALTS has a Gross Margin (47.46%) which is in line with its industry peers.

ALTS's Gross Margin has improved in the last couple of years.

The Profit Margin and Operating Margin are not available for ALTS so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	47.46%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y31.18%

GM growth 5Y17.71%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for ALTS has been increased compared to 1 year ago.

ALTS has more shares outstanding than it did 5 years ago.

ALTS has a worse debt/assets ratio than last year.

2.2 Solvency

ALTS has an Altman-Z score of 0.48. This is a bad value and indicates that ALTS is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 0.48, ALTS is doing worse than 60.85% of the companies in the same industry.

ALTS has a Debt/Equity ratio of 0.76. This is a neutral value indicating ALTS is somewhat dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.76, ALTS is in line with its industry, outperforming 57.45% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.76
Debt/FCF	N/A
Altman-Z	0.48

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 0.88 indicates that ALTS may have some problems paying its short term obligations.

With a Current ratio value of 0.88, ALTS is not doing good in the industry: 61.28% of the companies in the same industry are doing better.

ALTS has a Quick Ratio of 0.88. This is a bad value and indicates that ALTS is not financially healthy enough and could expect problems in meeting its short term obligations.

With a Quick ratio value of 0.88, ALTS is not doing good in the industry: 60.85% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	0.88
Quick Ratio	0.88

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 74.35% over the past year.

Looking at the last year, ALTS shows a very strong growth in Revenue. The Revenue has grown by 926.05%.

ALTS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -18.62% yearly.

EPS 1Y (TTM)74.35%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-799%

Revenue 1Y (TTM)926.05%

Revenue growth 3Y-32.08%

Revenue growth 5Y-18.62%

Sales Q2Q%194.05%

3.2 Future

The Earnings Per Share is expected to grow by 28.61% on average over the next years. This is a very strong growth

The Revenue is expected to grow by 65.13% on average over the next years. This is a very strong growth

EPS Next Y-87.54%

EPS Next 2Y-4.52%

EPS Next 3Y28.61%

EPS Next 5YN/A

Revenue Next Year205.43%

Revenue Next 2Y125.77%

Revenue Next 3Y84.48%

Revenue Next 5Y65.13%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALTS. In the last year negative earnings were reported.

Also next year ALTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as ALTS's earnings are expected to grow with 28.61% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-4.52%

EPS Next 3Y28.61%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALTS does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

ALT5 SIGMA CORP

NASDAQ:ALTS (1/7/2026, 8:15:49 PM)

After market: 1.55 +0.09 (+6.16%)

1.46

-0.08 (-5.19%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)11-18 2025-11-18

Earnings (Next)03-26 2026-03-26

Inst Owners45.72%

Inst Owner Change0%

Ins Owners0.69%

Ins Owner Change0%

Market Cap160.05M

Revenue(TTM)22.25M

Net Income(TTM)-16.67M

Analysts82.86

Price Target18.36 (1157.53%)

Short Float %16.33%

Short Ratio3.66

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	7.19
P/FCF	N/A
P/OCF	N/A
P/B	5.35
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-1

EYN/A

EPS(NY)-0.61

Fwd EYN/A

FCF(TTM)-0.04

FCFYN/A

OCF(TTM)-0.04

OCFYN/A

SpS0.2

BVpS0.27

TBVpS-0.14

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-17.6%
ROE	-55.73%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	47.46%
FCFM	N/A

ROA(3y)-8.77%

ROA(5y)-34.52%

ROE(3y)-9.86%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y31.18%

GM growth 5Y17.71%

F-Score4

Asset Turnover0.24

Health

		Industry Rank	Sector Rank
Debt/Equity	0.76
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.88
Quick Ratio	0.88
Altman-Z	0.48

F-Score4

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)74.35%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-799%

EPS Next Y-87.54%

EPS Next 2Y-4.52%

EPS Next 3Y28.61%

EPS Next 5YN/A

Revenue 1Y (TTM)926.05%

Revenue growth 3Y-32.08%

Revenue growth 5Y-18.62%

Sales Q2Q%194.05%

Revenue Next Year205.43%

Revenue Next 2Y125.77%

Revenue Next 3Y84.48%

Revenue Next 5Y65.13%

EBIT growth 1Y2.79%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year57.09%

EBIT Next 3Y44.5%

EBIT Next 5Y44.66%

FCF growth 1Y-57.96%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-100.27%

OCF growth 3YN/A

OCF growth 5YN/A

ALT5 SIGMA CORP / ALTS FAQ

Can you provide the ChartMill fundamental rating for ALT5 SIGMA CORP?

ChartMill assigns a fundamental rating of 2 / 10 to ALTS.

Can you provide the valuation status for ALT5 SIGMA CORP?

ChartMill assigns a valuation rating of 1 / 10 to ALT5 SIGMA CORP (ALTS). This can be considered as Overvalued.

Can you provide the profitability details for ALT5 SIGMA CORP?

ALT5 SIGMA CORP (ALTS) has a profitability rating of 1 / 10.

How financially healthy is ALT5 SIGMA CORP?

The financial health rating of ALT5 SIGMA CORP (ALTS) is 0 / 10.

ALT5 SIGMA CORP (ALTS) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

ALT5 SIGMA CORP / ALTS FAQ

Can you provide the ChartMill fundamental rating for ALT5 SIGMA CORP?

Can you provide the valuation status for ALT5 SIGMA CORP?

Can you provide the profitability details for ALT5 SIGMA CORP?

How financially healthy is ALT5 SIGMA CORP?